4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-25-003195
CEO sold 6,164 shares at $69.51 ($428,448)
- CEO acquired 7,463 shares (option exercise)
- CEO gave 1,299 shares (gift)
- CEO gave 1,299 shares (gift)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Zovighian Bernard J · CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +7,463 | $45.28 | $337,900 | 66,545.9 | D |
| 2025-03-10 | Gift : show line 2 in the form 10b5-1 | −1,299 | 65,246.9 | D | ||
| 2025-03-10 | Sale : show line 3 in the form 10b5-1 | −6,164 | $69.51 | $428,448 | 59,082.9 | D |
| 2025-03-10 | Gift : show line 4 in the form 10b5-1 | +1,299 | 10,436 | I | ||
| Open-market sales · 6,164 sh · avg $69.51 · $428,448 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-10 | Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −7,463 | 7,462 | D |
Loading xslF345X05/doc4.xml…